By transferring to additional cancer cells, EVs sustain proliferation primarily through activation of signal transduction in the phosphatidylinositol 3-kinase / protein kinase B (PI3K/AKT) and the mitogen-activated protein kinase / extracellular signal-regulated kinase (MAPK/ERK) pathways[1-3]. The gene discussed is AKT1; the disease is cancer.